Bay State court calls time-out on Body Science patent lawsuits
January 21, 2013 by MassDevice staff
A Massachusetts judge stays a handful of patent infringement lawsuit filed by Body Science while the patents are reviewed by regulators.
U.S. District Court Judge Dennis Saylor ruled this month to put a hold on a patent infringement lawsuit between patient monitoring device makers Body Science, St. Jude Medical (NYSE:STJ) and a slate of other device makers in order to give regulators at the U.S. Patent & Trademark Office time to review the patents in question.
Texas device maker Body Science filed lawsuits against a handful of companies it claims are infringing on its patents for "Wireless Medical Diagnosis and Monitoring Equipment," according to legal documents.
The alleged infringement applies to pacemakers, ICDs and CRT devices with sensors that monitor heart activity and wirelessly transmit data to local data storage systems.
Sign up to get our free newsletters delivered right to your inbox.
Similar entries
- Show full page
- Login to post comments
-
Permalink
RECENT BLOG POSTS
- Rising healthcare costs not directly tied to medical technology, according to study
- CareFusion may be weighing 2 very different deals
- Medical Devices: What does it really mean to be disruptive?
- Smarter strategic moves bode well for Wright Medical
- The IRS, NSA, and Justice Department scandals and what they mean for HIPAA
- A Father's Day remembrance
- What I'd tell the graduating medical school class of 2013
- Silencing immune attacks in type 1 diabetes
- Eucomed guidance clarifies RoHS compliance for medical device companies
- How to simplify consents
Navigation
NEWS
J&J's Synthes unit wins $16M ruling in patent fight with Globus Medical
A Delaware jury sides with Johnson & Johnson's DePuy-Synthes subsidiary in a patent spat over 3...
Aneurysm: Covidien touts pivotal study on Pipeline embolization device
Results of pivotal study on Covidien subsidiary eV3's Pipeline cerebral aneurysm device, published in...
ForSight Vision5 gets new CEO, closes $9.3M funding round
Delphi Ventures' John Maroney joins ForSight Vision5 as president, CEO & Director as the...
Diabetes: Echo Therapeutics sends pre-submission package to FDA for Symphony needle-free CGM
Echo Therapeutics initiates discussions with the FDA on the regulatory pathway for its Symphony non-...
Real-world results cast doubt on renal denervation for high blood pressure
Study results revealed in Europe this week cast doubt on the efficacy of renal denervation for...
